Evidence map›Paper›PMID 24277845›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Transcriptomic and biochemical analyses identify a family of chlorhexidine efflux proteins.

Karl A Hassan, Scott M Jackson, Anahit Penesyan, Simon G Patching, Sasha G Tetu, Bart A Eijkelkamp, Melissa H Brown, Peter J F Henderson, Ian T Paulsen

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 174 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Potential of isoquinoline-alkaloid-richFrontiers in pharmacology · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. NosocomialInternational journal of molecular sciences · 2025
    Article
  9. Review
  10. Article
  11. Comprehensive Approaches to CombattingAntibiotics (Basel, Switzerland) · 2024
    Review
  12. Genomic insights into the adaptation of Acinetobacter johnsonii RB2-047 to the heavy metal-contaminated subsurface mine environment.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Karl A HassanDepartment of Chemistry and Biomolecular Sciences, Macquarie University, North Ryde, NSW 2109, Australia.
Scott M Jackson
Anahit Penesyan
Simon G Patching
Sasha G Tetu
Bart A Eijkelkamp
Melissa H Brown
Peter J F Henderson
Ian T Paulsen
Macquarie University · AUFlinders University · AUUniversity of Leeds · GBInstitute of Structural and Molecular Biology · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chlorhexidine is widely used as an antiseptic or disinfectant in both hospital and community settings. A number of bacterial species display resistance to this membrane-active biocide. We examined the transcriptomic response of a representative nosocomial human pathogen, Acinetobacter baumannii, to chlorhexidine to identify the primary chlorhexidine resistance elements. The most highly up-regulated genes encoded components of a major multidrug efflux system, AdeAB. The next most highly overexpressed gene under chlorhexidine stress was annotated as encoding a hypothetical protein, named here as AceI. Orthologs of the aceI gene are conserved within the genomes of a broad range of proteobacterial species. Expression of aceI or its orthologs from several other γ- or β-proteobacterial species in Escherichia coli resulted in significant increases in resistance to chlorhexidine. Additionally, disruption of the aceI ortholog in Acinetobacter baylyi rendered it more susceptible to chlorhexidine. The AceI protein was localized to the membrane after overexpression in E. coli. This protein was purified, and binding assays demonstrated direct and specific interactions between AceI and chlorhexidine. Transport assays using [(14)C]-chlorhexidine determined that AceI was able to mediate the energy-dependent efflux of chlorhexidine. An E15Q AceI mutant with a mutation in a conserved acidic residue, although unable to mediate chlorhexidine resistance and transport, was still able to bind chlorhexidine. Taken together, these data are consistent with AceI being an active chlorhexidine efflux protein and the founding member of a family of bacterial drug efflux transporters.

Indexed as

Acinetobacter baumanniiChlorhexidineCircular DichroismCloning, MolecularDrug Resistance, BacterialFluorescenceGene Expression ProfilingGene Expression Regulation, BacterialHigh-Throughput Screening AssaysMembrane Transport ProteinsMicroarray AnalysisMultigene FamilyMutagenesisChlorhexidineMembrane Transport Proteinsdrug resistancemembrane transportopportunistic pathogen

Identifiers

PMID24277845
PMCPMC3864336
OpenAlexW2017818338

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.